EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biotinylated Fluorescent Polymeric Nanoparticles for Enhanced Immunostaining

Tesla Yudhistira, Elisabete Cruz Da Silva, Antoine Combes, Maxime Lehmann, Andreas Reisch, Andrey S Klymchenko iD

Small Methods · 2023

DOI: 10.1002/smtd.202201452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2023. Verfasst von Tesla Yudhistira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Bioimagerie et Pathologies, UMR 7021 CNRS, Faculté de Pharmacie, Université de Strasbourg, 74, Route du Rhin, Illkirch, 67401, France. Hauptthemen laut MEDLINE: Fluorescent Dyes, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The performance of fluorescence immunostaining is physically limited by the brightness of organic dyes, whereas fluorescence labeling with multiple dyes per antibody can lead to dye self‐quenching. The present work reports a methodology of antibody labeling by biotinylated zwitterionic dye‐loaded polymeric nanoparticles (NPs). A rationally designed hydrophobic polymer, poly(ethyl methacrylate) bearing charged, zwitterionic and biotin groups (PEMA‐ZI‐biotin), enables preparation of small (14 nm) and bright fluorescent biotinylated NPs loaded with large quantities of cationic rhodamine dye with bulky hydrophobic counterion (fluorinated tetraphenylborate). The biotin exposure at the particle surface is confirmed by Förster resonance energy transfer with dye‐streptavidin conjugate. Single‐particle microscopy validates specific binding to biotinylated surfaces, with particle brightness 21‐fold higher than quantum dot‐585 (QD‐585) at 550 nm excitation. The nanoimmunostaining method, which couples biotinylated antibody (cetuximab) with bright biotinylated zwitterionic NPs through streptavidin, significantly improves fluorescence imaging of target epidermal growth factor receptors (EGFR) on the cell surface compared to a dye‐based labeling. Importantly, cetuximab labeled with PEMA‐ZI‐biotin NPs can differentiate cells with distinct expression levels of EGFR cancer marker. The developed nanoprobes can greatly amplify the signal from labeled antibodies, and thus become a useful tool in the high‐sensitivity detection of disease biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorescent DyesNanoparticlesBiotinStreptavidinCetuximabPolymers

Stichwörter der Autor:innen

EGF receptorsantibody conjugationdye-loaded polymeric nanoparticlesfluorescence imagingfluorescent nanoparticles

Substanzen

Fluorescent DyesBiotinStreptavidinCetuximabPolymers

Autor:innen und Institutionen

  • Laboratoire de Bioimagerie et Pathologies, UMR 7021 CNRS, Faculté de Pharmacie, Université de Strasbourg, 74, Route du Rhin, Illkirch, 67401, France.

ORCID-Profile: Andrey S Klymchenko

Förderung

  • European Research Council

Zitieren

APA

Yudhistira, T., Da Silva, E. C., Combes, A., Lehmann, M., Reisch, A., & Klymchenko, A. S. (2023). Biotinylated Fluorescent Polymeric Nanoparticles for Enhanced Immunostaining. Small Methods. https://doi.org/10.1002/smtd.202201452

Vancouver

Yudhistira T, Da Silva EC, Combes A, Lehmann M, Reisch A, Klymchenko AS. Biotinylated Fluorescent Polymeric Nanoparticles for Enhanced Immunostaining. Small Methods. 2023. doi:10.1002/smtd.202201452

BibTeX
@article{Yudhistira2023,
  author = {Yudhistira, Tesla and Da Silva, Elisabete Cruz and Combes, Antoine and Lehmann, Maxime and Reisch, Andreas and Klymchenko, Andrey S},
  title = {Biotinylated Fluorescent Polymeric Nanoparticles for Enhanced Immunostaining},
  journal = {Small Methods},
  year = {2023},
  doi = {10.1002/smtd.202201452}
}
Kostenlos starten →